Cargando…
Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
Background: Colon adenocarcinoma (COAD) is still the main cause of cancer deaths worldwide. Although immunotherapy has made progress in recent years, there is still a need to improve diagnosis, prognosis, and treatment tools. UL-16 binding protein 1 (ULBP1) is a ligand that activates the receptor na...
Autores principales: | Ruan, Guo-Tian, Xie, Hai-Lun, Zhu, Li-Chen, Ge, Yi-Zhong, Yan, Lin, Liao, Cun, Gong, Yi-Zhen, Shi, Han-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862730/ https://www.ncbi.nlm.nih.gov/pubmed/35211154 http://dx.doi.org/10.3389/fgene.2022.762514 |
Ejemplares similares
-
An Immunosensor for the Detection of ULBP2 Biomarker
por: Yang, Wen-Chi, et al.
Publicado: (2020) -
Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma
por: Xiang, Jinyu, et al.
Publicado: (2023) -
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
por: Easom, Nicholas J. W., et al.
Publicado: (2020) -
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma
por: Ruan, Guo-Tian, et al.
Publicado: (2021) -
Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis
por: Huang, Yuancheng, et al.
Publicado: (2022)